LIVE Panel Discussion, COVID-19: Strategic Implications on Biopharma

Please join us Thursday, April 2nd from 1-2 PM EST to listen to the LIVE panel, COVID 19: Strategic Implications on Biopharma. Following our COVID-19 thought leadership piece on the strategic implications for biopharma, our panelists look forward to taking a deeper dive in the following:

  • Lessons for biopharma from the 2001 and 2008 financial crisis
  • Biopharma strategy in this turbulent financial environment
  • Capital markets turmoil and how to navigate
  • Venture capital landscape for new funding
  • Strategic dealmaking anticipated trends

Introducing our panelists (from left to right):
Geoff Meyerson, CEO & Co-Founder, Locust Walk
Chris Ehrlich, Senior Managing Director, Global Head of Biopharma, Locust Walk
Brian Coleman, Managing Director, Global Head of Financing and Sales, Locust Walk
Timothy Ehrlich, Partner, Gunderson Dettmer


Register Here

If you would like to make sure your questions are asked by the panel, please email to share your questions.